Team:EPF Lausanne/Project

From 2010.igem.org

(Difference between revisions)
(Overview)
(Overview)
Line 65: Line 65:
[[Image:Movie chair.png|center|100px|caption]]  
[[Image:Movie chair.png|center|100px|caption]]  
 +
 +
= Further improvements =
 +
 +
The next step would be to test Asaia expressing the immunotoxin in mosquitoes to see if it significantly reduces the number of oocyst. We are currently collaborating with the Pasteur Institute in Paris to make further test on mosquitoes with our bacteria but unfortunately the results won't be available before this year's jamboree.
 +
 +
Some modeling experiments should also be done to try to measure the impact of introducing our modified bacteria in mosquitoes populations. According to our references, Asaia is transmitted from parent to offspring and also from one individual to the other but further measurement should be made to see how quick the spreading would be. Using these values, it might be possible to find out the best way to infect the most mosquitoes without risking an uncontrolled expansion of the bacteria population.

Revision as of 13:52, 25 October 2010



Overview

caption

The aim of our project is to help stopping the propagation of Malaria. To do so, we chose to act on the mosquito. Indeed, if we prevent the mosquito from being infected by malaria, it won't be able to transmit the parasite to healthy humans.

caption

Our idea is to engineer Asaia, a bacterium that is naturally present in the mosquito's intestinal tract.

Asaia project overview.png

Gut.png


This bacteria would express an immunotoxin and specific proteins to kill the plasmodium or prevent its entry into the epithelium.


    caption                caption

The immunotoxin and the proteins then fight the plasmodium and thus prevent the mosquito infection.



caption


So... ASAIA is the pink power against malaria.....







For a playful overview of our project, you can watch our great movie iGEM EPFL movie

caption


Further improvements

The next step would be to test Asaia expressing the immunotoxin in mosquitoes to see if it significantly reduces the number of oocyst. We are currently collaborating with the Pasteur Institute in Paris to make further test on mosquitoes with our bacteria but unfortunately the results won't be available before this year's jamboree.

Some modeling experiments should also be done to try to measure the impact of introducing our modified bacteria in mosquitoes populations. According to our references, Asaia is transmitted from parent to offspring and also from one individual to the other but further measurement should be made to see how quick the spreading would be. Using these values, it might be possible to find out the best way to infect the most mosquitoes without risking an uncontrolled expansion of the bacteria population.


wrap bottom